benign paroxysmal positional vertigo
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Subjects who are over 18 years old and have no gender limit and can cooperate to complete the examination; (2) Subjects who are clearly diagnosed as unilateral benign paroxysmal positional vertigo (unilateral posterior semicircular canal BPPV or horizontal semicircular canal BPPV); (3) The subject or his legal representative can understand the purpose of the research, show sufficient compliance with the research protocol, and sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) The duration of the subject's benign paroxysmal positional vertigo attack was less than 3 days or more than 3 months; (2) The subject has severe cervical spine diseases, fractures, and traumatic brain injuries, such as those who do not allow physical activity, and acute attacks of vertigo caused by various causes; (3) Subjects have contraindications to the use of test products; (4) Subjects with serious cardiovascular and cerebrovascular diseases or organ failure; (5) Nursing women or pregnant women; (6) Subjects who have participated in any other drug or medical device clinical trials within the last 3 months; (7) Subjects that the investigator considers inappropriate to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reset treatment effect; | — |
Countries
China
Contacts
Shanghai Sixth People's Hospital